Precious Metals This slice is part of the broader Commodities - Metals theme.
Precious Metals names often move on drivers that differ from the rest of Commodities - Metals. Isolating this segment keeps earnings logic and news flow aligned with one part of the value chain.
Membership is based on Next Big Trend classification under Commodities - Metals → Precious Metals. Save the list as a watchlist to track updates without rebuilding Screener filters.
| Company | |||||||
|---|---|---|---|---|---|---|---|
| WPM | Wheaton Precious Metals Corp. | $61.3B | +1.15% | -13.91% | +15.35% | +25.14% | 41 |
| FNV | Franco-Nevada Corporation | $47.8B | +2.00% | -9.24% | +16.66% | +11.25% | 57 |
| RGLD | Royal Gold, Inc. | $19.9B | -0.49% | -11.94% | +4.66% | +17.50% | 47 |
| SBSW | D/B/A Sibanye-Stillwater Limited ADS | $7.2B | -1.00% | -24.47% | -28.44% | -11.09% | 12 |
| OR | OR Royalties Inc. | $6.5B | +0.59% | -7.40% | -3.07% | -15.09% | 63 |
| TFPM | Triple Flag Precious Metals Corp. | $6.2B | +0.59% | -9.49% | -7.36% | +1.16% | 56 |
| ELE | Elemental Royalty Corporation | $1.5B | -4.84% | -17.35% | +3.38% | -0.60% | 30 |
| VMET | Versamet Royalties Corporation | $934M | +0.35% | -17.02% | -13.94% | — | 32 |
| MTA | Metalla Royalty & Streaming Ltd. | $859M | -7.87% | -17.17% | +9.77% | +25.22% | 31 |
| GROY | Gold Royalty Corp. | $707M | +1.34% | -7.90% | -25.00% | -20.26% | 60 |
| GORO | Goldgroup Mining Inc. | $434M | 0.00% | -11.88% | -30.04% | +15.58% | 47 |
| VOXR | Vox Royalty Corp. | $353M | +1.40% | -12.86% | +7.85% | +20.89% | 44 |
| LODE | Comstock Inc. | $171M | -1.78% | -27.30% | -41.22% | -37.39% | 10 |
| PLG | Platinum Group Metals Ltd. | $165M | 0.00% | -19.62% | -46.19% | -55.12% | 23 |
| GRML | Greenland Mines Ltd | $79M | -35.46% | +40.33% | -59.31% | -80.20% | 99 |
Companies classified under the Commodities - Metals theme and the Precious Metals sub-theme within Next Big Trend's catalog.
Yes. Signed-in users can save the current constituents from this page as a named watchlist.
No. It is a research universe for screening, not a recommendation.